The budget will include 5.2 billion Yen for drug discovery platform technology development project for the next generation of treatment and diagnostic realization”, and 2,5 billion Yen “towards the industrialization of regenerative medicine evaluation fundamental technology development business”. Both budgets are equal to the fiscal 2014 initial budget. “

Nikkei Biotech news release, Jan. 22, 2015